Back to Journals » Drug Design, Development and Therapy » Volume 13

Subcutaneous bortezomib might be standard of care for patients with multiple myeloma: a systematic review and meta-analysis

Total article views   HTML views PDF downloads Totals
6,505 Dovepress* 5,846+ 1,150 6,996
PubMed Central* 659 228 887
Totals 6,505 1,378 7,883
*Since 16 May 2019

View citations on PubMed Central and Google Scholar